The role of mTOR signaling in the regulation of protein synthesis and muscle mass during immobilization in mice
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The maintenance of skeletal muscle mass contributes substantially to health and to issues associated with the quality of life. It has been well recognized that skeletal muscle mass is regulated by mechanically induced changes in protein synthesis, and that signaling by mTOR is necessary for an increase in protein synthesis and the hypertrophy that occurs in response to increased mechanical loading. However, the role of mTOR signaling in the regulation of protein synthesis and muscle mass during decreased mechanical loading remains largely undefined. In order to define the role of mTOR signaling, we employed a mouse model of hindlimb immobilization along with pharmacological, mechanical and genetic means to modulate mTOR signaling. The results first showed that immobilization induced a decrease in the global rates of protein synthesis and muscle mass. Interestingly, immobilization also induced an increase in mTOR signaling, eIF4F complex formation and cap-dependent translation. Blocking mTOR signaling during immobilization with rapamycin not only impaired the increase in eIF4F complex formation, but also augmented the decreases in global protein synthesis and muscle mass. On the other hand, stimulating immobilized muscles with isometric contractions enhanced mTOR signaling and rescued the immobilization-induced decrease in global protein synthesis through a rapamycin-sensitive mechanism that was independent of ribosome biogenesis. Unexpectedly, the effects of isometric contractions were also independent of eIF4F complex formation. Similar to isometric contractions, overexpression of Rheb in immobilized muscles enhanced mTOR signaling, cap-dependent translation and global protein synthesis, and prevented the reduction in fiber size. Therefore, we conclude that the activation of mTOR signaling is both necessary and sufficient to alleviate the decreases in protein synthesis and muscle mass that occur during immobilization. Furthermore, these results indicate that the activation of mTOR signaling is a viable target for therapies that are aimed at preventing muscle atrophy during periods of mechanical unloading.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546 · cited 1×
“…proliferator-activated receptor γ coactivator 1α (PGC1α) than glycolytic fiber types, and that overexpression of PGC1α inhibits the expression of atrophy-related genes as well as denervation- and fasting-induced muscle atrophy (Lin et al., 2002; Russell et al., 2003; Sandri et al., 2006).”
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
The healthcare costs of sarcopenia in the United States
Janssen, I., Shepard, D. S., Katzmarzyk, P. T., & Roubenoff, R. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52014.x · Cited by 1,546
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237 · cited 1×
“Previous studies have demonstrated that an increase in phosphatidylinositol 3-kinase (PI3K)-protein kinase B (PKB) pathway activity can activate mTOR signaling by inhibiting the tuberous sclerosis complex (TSC), which converts active GTPRheb into inactive GDP-Rheb (Huang and Manning, 2008).”
Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., Goldberg, A. L., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607795103 · Cited by 974 · cited 2×
“Indeed, it has been found that the expression of PGC1α is dramatically reduced in response to immobilization and denervation (Kang and Ji, 2013; Sandri et al., 2006).”
Srikanthan, P., & Karlamangla, A. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0435 · Cited by 785
Kumar, V., Selby, A., Rankin, D., Patel, R., Atherton, P., Hildebrandt, W., Williams, J., Smith, K., Seynnes, O., Hiscock, N., et al. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.164483 · Cited by 740 · cited 1×
“For instance, previous studies have shown that the activation of mTOR signaling positively correlates with contraction-induced increases in the rate of protein synthesis and training-induced increases in muscle mass (Baar and Esser, 1999; Kumar et al., 2009; Terzis et al., 2008).”
Baar, K., & Esser, K. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.1.c120 · Cited by 726
Drummond, M. J., Fry, C. S., Glynn, E. L., Dreyer, H. C., Dhanani, S., Timmerman, K. L., Volpi, E., & Rasmussen, B. B. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.163816 · Cited by 439 · cited 4×
“For instance, it has been shown that rapamycin, a highly specific inhibitor of mTOR signaling, can prevent the increases in p70 phosphorylation and protein synthesis that are induced by various forms of mechanical loading, such as resistance exercise, blood flow restriction exercise and passive stretch (Drummond et al…”
InfluentialMuscle Mass Index As a Predictor of Longevity in Older Adults
Srikanthan, P., & Karlamangla, A. S. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.02.007 · Cited by 382 · cited 1×
“…muscle comprises approximately 40% of total body mass, and the loss of its mass is highly associated with a low quality of life, an increased risk of morbidity and mortality, as well as elevated healthcare costs (Janssen et al., 2004; Srikanthan and Karlamangla, 2011, 2014; Zhou et al., 2010).”
Coordinated regulation of protein synthesis and degradation by mTORC1
Zhang, Y., Nicholatos, J., Dreier, J. R., Ricoult, S. J. H., Widenmaier, S. B., Hotamisligil, G. S., Kwiatkowski, D. J., & Manning, B. D. (2014) · Nature · doi:10.1038/nature13492 · Cited by 350 · cited 2×
“…of mTOR signaling can positively regulate protein synthesis and muscle mass during mechanical unloading; however, as mentioned in the results, the activation of mTOR can also promote protein degradation through multiple mechanisms (Harrington et al., 2005; Stitt et al., 2004; Zhang et al., 2014).”
Alterations of protein turnover underlying disuse atrophy in human skeletal muscle
Phillips, S. M., Glover, E. I., & Rennie, M. J. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00452.2009 · Cited by 322 · cited 1×
“During mechanical unloading, skeletal muscles undergo rapid disuse atrophy and this occurs primarily through a decrease in the rate of protein synthesis (Phillips et al., 2009; Rennie et al., 2010).”
The role of skeletal muscle mTOR in the regulation of mechanical load‐induced growth
Goodman, C. A., Frey, J. W., Mabrey, D. M., Jacobs, B. L., Lincoln, H. C., You, J., & Hornberger, T. A. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.218255 · Cited by 297 · cited 8×
“(B-D) Mice were subjected to IM for 3 or 7 days, or a non-immobilized control condition (IM 0), and injected with puromycin at 30 min prior to muscle collection for the measurement of protein synthesis by SUnSET.”
InfluentialSelf-citationGibson, J. N. A., Smith, K., & Rennie, M. J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92417-8 · Cited by 270 · cited 2×
“In immobilized muscles, isometric contractions enhance mTOR signaling and rescue the decrease in protein synthesis via a rapamycin-sensitive mechanism Previous human studies have shown that electrically evoked contractions can prevent disuse-induced reductions in the rate of protein synthesis and muscle size (Gibson e…”
Terzis, G., Georgiadis, G., Stratakos, G., Vogiatzis, I., Kavouras, S., Manta, P., Mascher, H., & Blomstrand, E. (2007) · European Journal of Applied Physiology · doi:10.1007/s00421-007-0564-y · Cited by 242 · cited 1×
“For instance, previous studies have shown that the activation of mTOR signaling positively correlates with contraction-induced increases in the rate of protein synthesis and training-induced increases in muscle mass (Baar and Esser, 1999; Kumar et al., 2009; Terzis et al., 2008).”
Nutritional strategies to attenuate muscle disuse atrophy
Wall, B. T., & van Loon, L. J. (2013) · Nutrition Reviews · doi:10.1111/nure.12019 · Cited by 228
Ribosome biogenesis: Emerging evidence for a central role in the regulation of skeletal muscle mass
Chaillou, T., Kirby, T. J., & McCarthy, J. J. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24604 · Cited by 211
Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol
Kline, W. O., Panaro, F. J., Yang, H., & Bodine, S. C. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00873.2006 · Cited by 177
Gundermann, D. M., Walker, D. K., Reidy, P. T., Borack, M. S., Dickinson, J. M., Volpi, E., & Rasmussen, B. B. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00600.2013 · Cited by 143 · cited 4×
“For instance, it has been shown that rapamycin, a highly specific inhibitor of mTOR signaling, can prevent the increases in p70 phosphorylation and protein synthesis that are induced by various forms of mechanical loading, such as resistance exercise, blood flow restriction exercise and passive stretch (Drummond et al…”
InfluentialDyle, M. C., Ebert, S. M., Cook, D. P., Kunkel, S. D., Fox, D. K., Bongers, K. S., Bullard, S. A., Dierdorff, J. M., & Adams, C. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.556241 · Cited by 138 · cited 1×
“Recent studies have also shown that the administration of tomatidine and capsaicin, natural small molecules that stimulate mTOR signaling, can increase muscle mass in immobilized and hindlimb-suspended muscles, respectively (Dyle et al., 2014; Ito et al., 2013).”
You, J.-S., Park, M.-N., Song, W., & Lee, Y.-S. (2010) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h10-022 · Cited by 88
Self-citation
Cited by
AKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772
Role of Inactivity in Chronic Diseases: Evolutionary Insight and Pathophysiological Mechanisms
Booth, F. W., Roberts, C. K., Thyfault, J. P., Ruegsegger, G. N., & Toedebusch, R. G. (2017) · Physiological Reviews · doi:10.1152/physrev.00019.2016 · Cited by 696
Mouse models of sarcopenia: classification and evaluation
Xie, W., He, M., Yu, D., Wu, Y., Wang, X., Lv, S., Xiao, W., & Li, Y. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12709 · Cited by 231
Role of mTORC1 in mechanically induced increases in translation and skeletal muscle mass
Goodman, C. A. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01011.2018 · Cited by 133
Mitochondrial dynamics in cancer-induced cachexia
van der Ende, M., Grefte, S., Plas, R., Meijerink, J., Witkamp, R. F., Keijer, J., & van Norren, K. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.07.008 · Cited by 87
Metadata
- Authors
- You, J.-S., Anderson, G. B., Dooley, M. S., & Hornberger, T. A.
- Venue
- Disease Models & Mechanisms
- Publisher
- The Company of Biologists
- Published
- 2015-09-01
- Volume
- 8
- Issue
- 9
- Pages
- 1059-1069
- ISSN
- 1754-8403 (ISSN-L)
- 1754-8411
- OpenAlex
- W2163855569
- Cited by
- 150
- References
- 23
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.